EE04092B1 - Rasestumisvastase vahendi komplekt - Google Patents

Rasestumisvastase vahendi komplekt

Info

Publication number
EE04092B1
EE04092B1 EEP200000211A EEP200000211A EE04092B1 EE 04092 B1 EE04092 B1 EE 04092B1 EE P200000211 A EEP200000211 A EE P200000211A EE P200000211 A EEP200000211 A EE P200000211A EE 04092 B1 EE04092 B1 EE 04092B1
Authority
EE
Estonia
Prior art keywords
contraceptive kit
contraceptive
kit
Prior art date
Application number
EEP200000211A
Other languages
English (en)
Inventor
Jay Gast Michael
Paul Miller Christopher
Original Assignee
American Home Products Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corporation filed Critical American Home Products Corporation
Publication of EE200000211A publication Critical patent/EE200000211A/et
Publication of EE04092B1 publication Critical patent/EE04092B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200000211A 1997-11-06 1998-11-04 Rasestumisvastase vahendi komplekt EE04092B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96508397A 1997-11-06 1997-11-06
PCT/US1998/023427 WO1999024027A2 (en) 1997-11-06 1998-11-04 Anti-estrogen plus progestin containing oral contraceptives

Publications (2)

Publication Number Publication Date
EE200000211A EE200000211A (et) 2001-04-16
EE04092B1 true EE04092B1 (et) 2003-08-15

Family

ID=25509417

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000211A EE04092B1 (et) 1997-11-06 1998-11-04 Rasestumisvastase vahendi komplekt

Country Status (28)

Country Link
EP (1) EP1051179B1 (et)
JP (1) JP2001522798A (et)
CN (1) CN1278732A (et)
AR (1) AR016667A1 (et)
AT (1) ATE304359T1 (et)
AU (2) AU760540B2 (et)
BG (1) BG104451A (et)
BR (1) BR9813982A (et)
CA (1) CA2307210A1 (et)
CZ (1) CZ294155B6 (et)
DE (1) DE69831605T2 (et)
DK (1) DK1051179T3 (et)
EA (1) EA200000492A1 (et)
EE (1) EE04092B1 (et)
ES (1) ES2246541T3 (et)
GE (1) GEP20043290B (et)
HR (1) HRP20000269A2 (et)
HU (1) HUP0100293A3 (et)
ID (1) ID24568A (et)
IL (1) IL135621A0 (et)
NO (1) NO20002167L (et)
NZ (1) NZ503890A (et)
PL (1) PL340623A1 (et)
SK (1) SK6482000A3 (et)
TR (1) TR200001268T2 (et)
UA (1) UA68365C2 (et)
WO (1) WO1999024027A2 (et)
ZA (1) ZA9810136B (et)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120263A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to prevent bone loss-progesterone and estrogen agonists
US6479535B1 (en) 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
PT1076558E (pt) * 1998-05-15 2003-11-28 Wyeth Corp 2-fenil-1-¬4-(2-aminoetoxi)-benzil|-indole em combinacao com estrogenios
US6380166B1 (en) 1999-09-13 2002-04-30 American Home Products Corporation Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols
JP2003509435A (ja) * 1999-09-13 2003-03-11 ワイス ２−（４−ヒドロキシフェニル）−１−［４−（２−アミン−１−イルエトキシ）ベンジル］−１ｈ−インドール−５−オールのグルコピラノシド複合体
US6376486B1 (en) * 2000-07-06 2002-04-23 American Home Products Corporation Methods of inhibiting sphincter incontinence
PL367094A1 (en) 2001-07-31 2005-02-21 Pfizer Products Inc. Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
PL1809602T3 (pl) 2004-10-27 2009-04-30 Janssen Pharmaceutica Nv Pochodne indolowe przydatne jako modulatory receptora progesteronu
FR2880625B1 (fr) * 2005-01-07 2007-03-09 Sanofi Aventis Sa Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
UY29527A1 (es) * 2005-05-13 2006-12-29 Schering Ag Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
DE102008057230A1 (de) * 2008-11-11 2010-05-12 Bayer Schering Pharma Aktiengesellschaft Synergistische pharmazeutische Kombination mit einem Estrogenrezeptorantagonisten und einem Progestin
PL2580210T3 (pl) 2010-06-10 2017-09-29 Seragon Pharmaceuticals, Inc. Modulatory receptora estrogenowego i ich zastosowania
BR112014014124A2 (pt) 2011-12-14 2017-08-22 Seragon Pharmaceutical Inc Moduladores do receptor de estrogênio fluorados e usos dos mesmos
HUE055321T2 (hu) 2015-10-01 2021-11-29 Olema Pharmaceuticals Inc Tetrahidro-1H-pirido[3,4-b]indol anti-ösztrogén hatóanyagok
US10118910B2 (en) 2015-12-09 2018-11-06 The Board Of Trustees Of The University Of Illinois Benzothiophene-based selective estrogen receptor downregulators
WO2017197055A1 (en) 2016-05-10 2017-11-16 C4 Therapeutics, Inc. Heterocyclic degronimers for target protein degradation
CN109562113A (zh) 2016-05-10 2019-04-02 C4医药公司 用于靶蛋白降解的螺环降解决定子体
WO2017197046A1 (en) 2016-05-10 2017-11-16 C4 Therapeutics, Inc. C3-carbon linked glutarimide degronimers for target protein degradation
MX2019000200A (es) 2016-07-01 2019-09-26 G1 Therapeutics Inc Agentes antiproliferativos basados en pirimidina.
WO2018081168A2 (en) 2016-10-24 2018-05-03 The Board Of Trustees Of The University Of Illinois Benzothiophene-based selective mixed estrogen receptor downregulators
BR112019013814A2 (pt) 2017-01-06 2020-01-21 G1 Therapeutics Inc método para tratamento de câncer ou de um tumor em um indivíduo, composição farmacêutica, combinação, e, kit.
JP2020507566A (ja) 2017-02-10 2020-03-12 ジー１ セラピューティクス， インコーポレイテッド ベンゾチオフェンエストロゲン受容体モジュレーター
KR102659211B1 (ko) 2017-06-29 2024-04-18 쥐원 쎄라퓨틱스, 인크. G1t38의 형체 형태 및 그의 제조 방법
EP3897631A4 (en) 2018-12-20 2022-11-23 C4 Therapeutics, Inc. TARGETED PROTEIN DEGRADATION
WO2024030968A1 (en) 2022-08-03 2024-02-08 Brystol-Myers Squibb Company Compounds for modulating ret protein
WO2024097980A1 (en) 2022-11-04 2024-05-10 Bristol-Myers Squibb Company Ret-ldd protein inhibitors
WO2024097989A1 (en) 2022-11-04 2024-05-10 Bristol-Myers Squibb Company Ret-ldd protein degraders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA716118B (en) * 1970-10-05 1972-05-31 Richardson Merrell Inc Contraception
ZA9510926B (en) * 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
IL120263A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to prevent bone loss-progesterone and estrogen agonists
IL120266A (en) * 1996-02-28 2005-05-17 Pfizer Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
ATE206701T1 (de) * 1996-04-19 2001-10-15 American Home Prod Östrogene verbindungen
US5747480A (en) * 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive

Also Published As

Publication number Publication date
HUP0100293A3 (en) 2002-12-28
JP2001522798A (ja) 2001-11-20
NO20002167D0 (no) 2000-04-27
BG104451A (en) 2000-12-29
GEP20043290B (en) 2004-07-26
DE69831605T2 (de) 2006-06-14
PL340623A1 (en) 2001-02-12
UA68365C2 (en) 2004-08-16
NZ503890A (en) 2002-08-28
HUP0100293A2 (hu) 2001-10-28
EP1051179B1 (en) 2005-09-14
EE200000211A (et) 2001-04-16
DE69831605D1 (de) 2005-10-20
ES2246541T3 (es) 2006-02-16
EP1051179A2 (en) 2000-11-15
AR016667A1 (es) 2001-07-25
WO1999024027A3 (en) 1999-07-15
ZA9810136B (en) 2000-05-05
CN1278732A (zh) 2001-01-03
CA2307210A1 (en) 1999-05-20
ATE304359T1 (de) 2005-09-15
HRP20000269A2 (en) 2000-12-31
SK6482000A3 (en) 2000-11-07
DK1051179T3 (da) 2005-10-31
CZ294155B6 (cs) 2004-10-13
NO20002167L (no) 2000-06-28
EA200000492A1 (ru) 2000-10-30
IL135621A0 (en) 2001-05-20
AU760540B2 (en) 2003-05-15
AU2003204896B2 (en) 2006-06-15
TR200001268T2 (tr) 2001-01-22
CZ20001661A3 (cs) 2000-12-13
ID24568A (id) 2000-07-27
BR9813982A (pt) 2000-09-26
AU1303199A (en) 1999-05-31
WO1999024027A2 (en) 1999-05-20

Similar Documents

Publication Publication Date Title
EE04092B1 (et) Rasestumisvastase vahendi komplekt
ATA93198A (de) Fluoxetinpellets
DE69810954D1 (de) 7-methyliden-5-oxo-kondensierte naphtopyrane
DE69733833D1 (de) Mannliches kondom
ID23497A (id) Kombinasi pembungkus-deterjen
DE69821845D1 (de) Ostomievorrichtung
DE69801566T2 (de) Polyisocyanatxerogele
DK1334725T3 (da) Östroprogestativt antikonceptionsmiddel
DE69817687D1 (de) Positiv-Fotoresist-Zusammensetzung
NO995147D0 (no) Kontrastmidler
DK0991384T3 (da) Vandladningshjælpemiddel
DK0853933T3 (da) Ostomikobling
ATA111897A (de) Kimme
ATE236897T1 (de) 3-benzylpiperidine
ATA112597A (de) Snowboard - bindung
FI973782A0 (fi) Linjefrekvenseffektkonverter fraon vaexelstroem till vaexelstroem
ATA86797A (de) Verschleissschuh
FI3588U1 (fi) Rakennussarja
KR980000759U (ko) 콘돔
FI974129A (fi) Apuväline
ATA46498A (de) Kunststoffgleitbahn
BR9700383A (pt) Kit duplicador
UA1593S (uk) Контрацептив вагінальний
FI971467A0 (fi) Saekerhetshandtag till trappstege
FI971309A0 (fi) Bakskiva till ostpresskar

Legal Events

Date Code Title Description
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

MM4A Lapsed by not paying the annual fees

Effective date: 20051104